CFTR Modulators in Pregnancy and Postpartum
Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.
- EligibilityCriteria: Inclusion Criteria:  Woman with cystic fibrosis who is pregnant and treated with Kaftrio. Newborn infant to the above mentioned woman  Exclusion Criteria:  none - HealthyVolunteers: No - Gender: All - MaximumAge: 50 Years - StdAgeList: Child, Adult - StudyPopulation: Woman with cystic fibrosis who is pregnant and treated with Kaftrio and her newborn infant - SamplingMethod: Probability Sample